Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 6/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6310916 | 0.85 | RAB9A (0.45) | LMNAADRB1ADRB3NAMPTSMN1; SMN2 | |
| SCHEMBL3069625 | 0.81 | LMNA (0.45) | LMNAKMT2ATDP1ADRB1ADRB3 | |
| SCHEMBL6394358 | 0.81 | PSMB5 (0.48) | LMNAKMT2ATDP1ADRB1ADRB3 | |
| SCHEMBL3103554 | 0.80 | LMNA (0.43) | LMNAKMT2ATDP1ADRB1ADRB3 | |
| SCHEMBL27323312 | 0.77 | ALDH1A1 (0.58) | KMT2ATDP1 | |
| SCHEMBL6316393 | 0.76 | LMNA (0.50) | LMNAKMT2ATDP1NAMPTTP53 | |
| SCHEMBL5160706 | 0.76 | LMNA (0.48) | LMNAKMT2ASMN1; SMN2KCNA5 | |
| SCHEMBL5929541 | 0.76 | LMNA (0.48) | LMNAKMT2ASMN1; SMN2KCNA5 | |
| SCHEMBL6308945 | 0.76 | LMNA (0.40) | LMNAKMT2ATDP1ADRB1ADRB3 | |
| SCHEMBL3081201 | 0.75 | TSHR (0.46) | LMNAKMT2ATDP1ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050277663-A1 | 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides | ATP CAPITAL LP | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277663-A1 | 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides | CYP21A2, HAO1, AHR | LMNA 3281/4885KMT2A 1213/4885TDP1 2709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.